Prescription Drug News and Research

RSS

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.

8 May 2013

Despite outreach efforts, many eligible seniors are turning down health subsidy program

The Low Income Subsidy for Medicare Part D is a rare beast in economics research. The subsidy provides prescription drug coverage essentially free for low-income adults. That means it is what economists call a dominant option.

7 May 2013

Obama 'comfortable' with morning-after pill sales at 15

President Barack Obama said he is "very comfortable" with the Food and Drug Administration rule announced this week to make the so-called morning after pill available without a prescription to women and girls who are at least 15 -- younger than the current limit of 17.

4 May 2013

Roundup: Calif. regulator says insurer's proposed rate hikes are 'unreasonable'; Iowa lawmakers push to deny abortion funding in Medicaid

California Insurance Commissioner Dave Jones said the nation's largest health insurer, UnitedHealth Group Inc., is imposing unreasonable rate hikes on about 5,000 small businesses. Jones said Wednesday that UnitedHealth couldn't justify the average annual increase of nearly 8 percent, which reflects both higher premiums and a reduction in benefits (Terhune, 5/1).

3 May 2013

First Edition: May 2, 2013

Today's headlines include reports about a new study detailing how expanded Medicaid access impacts beneficiaries' utilization of health care services and their overall physical health.

2 May 2013

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

A new report shows that the number of emergency department visits involving adverse reactions to the sleep medication zolpidem rose nearly 220 percent from 6,111 visits in 2005 to 19,487 visits in 2010.

2 May 2013

New collaboration provides access, allows users to make decisions based on data

Archimedes, Inc., a healthcare modeling and analytics company, announced today that it has begun collaborating with the United States Department of Health and Human Services and Centers for Medicare & Medicaid Services to provide unprecedented access to synthetic CMS claims data.

2 May 2013

Prescription drug 'track and trace' bill splits House lawmakers

House lawmakers are split on how the federal government should better track prescription drugs with one powerful Republican promising a "track and trace" law by August while Democrats press for stronger safeguards in the proposal.

29 Apr 2013

Actavis resolves patent litigation related to generic version of INTUNIV for treatment of ADHD

Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with Shire plc resolving outstanding patent litigation related to Actavis' generic version of INTUNIV® (guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.

26 Apr 2013

New Haven Pharmaceuticals gets venture loan facility from Horizon Technology Finance

Horizon Technology Finance Corporation ("Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and clean-tech industries, today announced it has closed a $2 million venture loan facility with New Haven Pharmaceuticals, Inc. ("NHP"), a developer of prescription pharmaceuticals that utilize currently marketed drugs or active pharmaceutical ingredients generally recognized as safe for use in therapeutic applications.

26 Apr 2013

IGI Laboratories net revenues increase 101% to $3.7M in first quarter 2013

IGI Laboratories, Inc., a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the first quarter ended March 31, 2013.

26 Apr 2013

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announced today that the US Food and Drug Administration has granted orphan-drug designation to the investigational drug XEN402 being developed for the treatment of pain associated with erythromelalgia.

24 Apr 2013

1 in 4 teens misused or abused a prescription drug at least once in their lifetime

New, nationally projectable survey results released today by The Partnership at Drugfree.org and MetLife Foundation confirmed that one in four teens has misused or abused a prescription (Rx) drug at least once in their lifetime - a 33 percent increase over the past five years.

23 Apr 2013

U.S. Drug Enforcement Administration to hold national drug take-back day this weekend

On April 27, the U.S. Drug Enforcement Administration will be running a national drug take-back day. It is an opportunity for everyone to safely remove unwanted, unused, or expired medication from medicine cabinets.

23 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Roundup: Ariz. lawmakers revive vetoed health care price transparency bill; Big tobacco starts health care payments to states

The Arizona Senate voted Monday to revive the major provisions of a medical pricing transparency bill that was vetoed by Gov. Jan Brewer just last week. Senate Bill 1115 by Republican Sen. Nancy Barto would have required health care providers to post prices for common medical procedures (Christie, 4/15).

17 Apr 2013

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.'s reformulated OxyContin (oxycodone hydrochloride controlled-release) tablets.

17 Apr 2013

Propranolol drug can improve language abilities, social functioning of people with ASD

People with an Autism Spectrum Disorder (ASD) often have trouble communicating and interacting with others because they process language, facial expressions and social cues differently.

16 Apr 2013

First Edition: April 16, 2013

Today's headlines include coverage of the Supreme Court oral arguments regarding whether patents should be granted for human genes.

16 Apr 2013

Ameritox study shows correlation between positive marijuana tests, misuse of prescription drugs

Ameritox, one of the nation's leaders in pain medication monitoring, announced new research today showing a correlation between positive marijuana tests and higher rates of potential prescription drug non-adherence among chronic pain medication users.

15 Apr 2013

Prescription Drug News and Research

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Despite outreach efforts, many eligible seniors are turning down health subsidy program

Obama 'comfortable' with morning-after pill sales at 15

Roundup: Calif. regulator says insurer's proposed rate hikes are 'unreasonable'; Iowa lawmakers push to deny abortion funding in Medicaid

First Edition: May 2, 2013

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

New collaboration provides access, allows users to make decisions based on data

Prescription drug 'track and trace' bill splits House lawmakers

Actavis resolves patent litigation related to generic version of INTUNIV for treatment of ADHD

New Haven Pharmaceuticals gets venture loan facility from Horizon Technology Finance

IGI Laboratories net revenues increase 101% to $3.7M in first quarter 2013

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

1 in 4 teens misused or abused a prescription drug at least once in their lifetime

U.S. Drug Enforcement Administration to hold national drug take-back day this weekend

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Roundup: Ariz. lawmakers revive vetoed health care price transparency bill; Big tobacco starts health care payments to states

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

Propranolol drug can improve language abilities, social functioning of people with ASD

First Edition: April 16, 2013

Ameritox study shows correlation between positive marijuana tests, misuse of prescription drugs

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News